Vicki Wheelock MD HDSA Center of Excellence at UC Davis ...

More documents

Recommendations

Info

Who can participate in clinical trials? • Ability to give informed consent • Age criteria • Other medical conditions – Safety labs • Psychiatric conditions – Must be stable • Other medications – Some may not be allowed
How much time is required? • Studies vary in duration, number of activities carried out at study visits – Observational studies can last many years • Visits are usually just once a year – Clinical trials could last 3 months – 5 years • Visits are frequent for Phase II trials (every 1-4 weeks) • Visits every 1 – 6 months in longer Phase III studies – Initial study visits usually last 2 - 3 hours – Follow-up visits may take as little as 15 minutes, or as long as several hours – Sometimes there may be telephone contacts made between visits
Page 1 and 2: Vicki Wheelock MD HDSA Center of Ex
Page 3 and 4: Presenter Disclosures Dr. Vicki Whe
Page 5 and 6: Clinical research studies, especial
Page 7 and 8: The pathway to finding new drugs Pr
Page 9 and 10: What are double blind, randomized,
Page 11: Who can participate in clinical tri
Page 15 and 16: What kinds of activities take place
Page 17 and 18: What kinds of activities take place
Page 19 and 20: What about privacy? • Confidentia
Page 21 and 22: Current observational studies Study
Page 23 and 24: The HD Pipeline Source: Marsha Mill
Page 25 and 26: Results: Tetrabenazine H · S · G
Page 27 and 28: Getting involved in research: Five
Page 29 and 30: There are reasons for and against v
Page 31 and 32: COHORT COHORT • Cooperative Hunti
Page 33 and 34: • Sponsor: NIH PREDICT study •
Page 36 and 37: 2CARE Study • Sponsor: NIH, Phase
Page 38 and 39: HART trial • Sponsor: Neurosearch
Page 40 and 41: CREST-E study • Sponsor: NIH, Pha
Page 42: H · S · G Huntington · Study ·

Vicki Wheelock MD HDSA Center of Excellence at UC Davis ...

Create successful ePaper yourself

Delete template?

Save as template?